关注
Alexey Bazarov
Alexey Bazarov
CHO PLUS
在 CHO-plus.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
D Horiuchi, L Kusdra, NE Huskey, S Chandriani, ME Lenburg, ...
Journal of Experimental Medicine 209 (4), 679-696, 2012
3892012
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
D Horiuchi, R Camarda, AY Zhou, C Yau, O Momcilovic, S Balakrishnan, ...
Nature medicine 22 (11), 1321-1329, 2016
1652016
Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis
E Raderschall, A Bazarov, J Cao, R Lurz, A Smith, W Mann, HH Ropers, ...
Journal of cell science 115 (1), 153-164, 2002
1312002
Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells
EM Weissinger, G Eissner, C Grammer, S Fackler, B Haefner, LS Yoon, ...
Molecular and cellular biology 17 (6), 3229-3241, 1997
851997
A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation
AV Bazarov, S Adachi, SF Li, MK Mateyak, S Wei, JM Sedivy
Cancer research 61 (3), 1178-1186, 2001
582001
Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies
R Mukhopadhyay, SV Costes, AV Bazarov, WC Hines, MH Barcellos-Hoff, ...
Breast Cancer Research 12, 1-15, 2010
422010
Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes
AV Bazarov, WC Hines, R Mukhopadhyay, A Beliveau, S Melodyev, ...
Cell Cycle 8 (20), 3373-3378, 2009
402009
p16INK4a‐mediated suppression of telomerase in normal and malignant human breast cells
AV Bazarov, M Van Sluis, WC Hines, E Bassett, A Beliveau, E Campeau, ...
Aging cell 9 (5), 736-746, 2010
392010
BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas
WC Hines, AV Bazarov, R Mukhopadhyay, P Yaswen
PLoS One 5 (3), e9738, 2010
312010
Host cells with artificial endosymbionts
CB Bell III, A Bazarov
US Patent 8,828,681, 2014
302014
The specific role of pRb in p16INK4A-mediated arrest of normal and malignant human breast cells
AV Bazarov, WJ Lee, I Bazarov, M Bosire, WC Hines, B Stankovich, ...
Cell cycle 11 (5), 1008-1013, 2012
282012
Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors
AV Bazarov, P Yaswen
Breast Cancer Research 13, 1-2, 2011
232011
A Simple Three-dimensional Hydrogel Platform Enables Ex Vivo Cell Culture of Patient and PDX Tumors for Assaying Their Response to Clinically Relevant …
KC Hribar, CJ Wheeler, A Bazarov, K Varshneya, R Yamada, P Buckley, ...
Molecular cancer therapeutics 18 (3), 718-725, 2019
212019
Host cells with artificial endosymbionts
CB Bell III, AV Bazarov
US Patent 8,956,873, 2015
202015
Host cells with artificial endosymbionts
CB Bell III, A Bazarov
US Patent 8,859,281, 2014
192014
Eukaryotic cells with artificial endosymbionts for multimodal detection
CB Bell III, A Bazarov
US Patent 9,023,612, 2015
172015
A tumor-suppressing function in the epithelial adhesion protein Trask
DS Spassov, CH Wong, G Harris, S McDonough, P Phojanakong, ...
Oncogene 31 (4), 419-431, 2012
162012
Host cell modification with artificial endosymbionts
CB Bell III, A Bazarov, A Wakeel, J Barrozo
US Patent 9,481,869, 2016
152016
Isolation of temperature-sensitive mutations in the c-raf-1 catalytic domain and expression of conditionally active and dominant-defective forms of Raf-1 in cultured mammalian …
KK Lu, AV Bazarov, LS Yoon, JM Sedivy
Cell Growth & Differentiation: the Molecular Biology Journal of the American …, 1998
111998
Host cells with artificial endosymbionts
C Bell III, A Bazarov
US Patent 9,085,764, 2015
92015
系统目前无法执行此操作,请稍后再试。
文章 1–20